We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+5.98%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$124M
AUM Growth
+$34.6M
(+39%)
Cap. Flow
+$32.8M
Cap. Flow
% of AUM
26.44%
Top 10 Holdings %
Top 10 Hldgs %
61.45%
Holding
51
New
18
Increased
5
Reduced
7
Closed
10
Top Buys
| 1 |
GSK
GSK
|
+$11.5M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
+$6.33M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$5.74M |
| 4 |
AET
Aetna Inc
AET
|
+$4.57M |
| 5 |
Amgen
AMGN
|
+$4.54M |
Top Sells
| 1 |
Merck
MRK
|
+$8.34M |
| 2 |
United Therapeutics
UTHR
|
+$5.98M |
| 3 |
PFNX
Pfenex Inc.
PFNX
|
+$5.15M |
| 4 |
UnitedHealth
UNH
|
+$3.13M |
| 5 |
GTS
Triple-S Management Corporation
GTS
|
+$2.23M |
Sector Composition
| 1 | Healthcare | 90.51% |
| 2 | Financials | 4.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $16.2M | 13.04% |
27,325
-766
| -3% | -$472K |
|
|
2
GSK
GSK
$103B
| $10.6M | 8.57% |
+204,000
| New | +$11.5M |
|
|
RXDX
3
DELISTED
Ignyta, Inc.
RXDX
| $7.89M | 6.36% |
+522,756
| New | +$6.33M |
|
|
AVDL
4
DELISTED
Avadel Pharmaceuticals
AVDL
| $6.78M | 5.47% |
+320,000
| New | +$5.74M |
|
|
PFNX
5
DELISTED
Pfenex Inc.
PFNX
| $6.71M | 5.42% |
346,128
-307,265
| -47% | -$5.15M |
|
6
Johnson & Johnson
JNJ
$611B
| $6.25M | 5.05% |
64,177
+19,177
| +43% | +$1.92M |
|
|
PETX
7
DELISTED
Aratana Therapeutics, Inc.
PETX
| $6.12M | 4.94% |
404,738
+226,188
| +127% | +$3.27M |
|
8
Cardinal Health
CAH
$53.9B
| $5.29M | 4.27% |
63,278
+5,278
| +9% | +$466K |
|
9
Addus HomeCare
ADUS
$2.03B
| $5.18M | 4.18% |
186,055
-3,411
| -2% | -$93.4K |
|
|
DMK
10
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $5.13M | 4.14% |
17,461
+604
| +4% | +$182K |
|
|
AET
11
DELISTED
Aetna Inc
AET
| $5.1M | 4.11% |
+40,000
| New | +$4.57M |
|
|
12
Amgen
AMGN
$192B
| $4.35M | 3.51% |
+28,349
| New | +$4.54M |
|
|
HNGR
13
DELISTED
Hanger Inc.
HNGR
| $4.12M | 3.33% |
+175,859
| New | +$4.1M |
|
14
Medtronic
MDT
$102B
| $4.11M | 3.31% |
+55,400
| New | +$4.23M |
|
15
Ascendis Pharma A/S
ASND
$17.4B
| $3.58M | 2.89% |
+202,525
| New | +$3.54M |
|
16
Alnylam Pharmaceuticals
ALNY
$37.6B
| $3.24M | 2.61% |
+27,000
| New | +$3.23M |
|
17
Stryker
SYK
$119B
| $3.18M | 2.57% |
+33,300
| New | +$3.16M |
|
18
Cigna
CI
$80.2B
| $2.86M | 2.31% |
+17,640
| New | +$2.44M |
|
19
Ironwood Pharmaceuticals
IRWD
$655M
| $2.86M | 2.31% |
+282,978
| New | +$3.29M |
|
20
Avanos Medical
AVNS
$1.17B
| $2.43M | 1.96% |
+60,000
| New | +$2.69M |
|
21
AbbVie
ABBV
$432B
| $2.24M | 1.81% |
33,291
-21,709
| -39% | -$1.42M |
|
|
ACHN
22
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.19M | 1.77% |
+247,000
| New | +$2.34M |
|
|
ANTH
23
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $2.05M | 1.66% |
+29,770
| New | +$1.38M |
|
|
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.65M | 1.33% |
+161,286
| New | +$1.78M |
|
25
SCYNEXIS
SCYX
$49M
| $1.43M | 1.15% |
2,027
+117
| +6% | +$84K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA